{"transactions":[{"id":729050,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-06-23T21:22:58.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":14950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on June 18, 2026. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2027."}],"balance_after":14950,"derivative":{"exercise_price":34.16,"expiration_date":"2036-06-18","underlying":"Common stock","underlying_shares":14950},"source":{"system":"sec-edgar","filing":"0001439222-26-000101","document":"wk-form4_1782249776.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000101/wk-form4_1782249776.xml","form_type":"4"}},{"id":729049,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2026-06-23T21:22:58.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":2927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2927,"derivative":{"underlying":"Common stock","underlying_shares":2927},"source":{"system":"sec-edgar","filing":"0001439222-26-000101","document":"wk-form4_1782249776.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000101/wk-form4_1782249776.xml","form_type":"4"}},{"id":729048,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2026-06-23T21:22:58.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":2816},"source":{"system":"sec-edgar","filing":"0001439222-26-000101","document":"wk-form4_1782249776.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000101/wk-form4_1782249776.xml","form_type":"4"}},{"id":729047,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-06-23T21:22:58.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":154156,"source":{"system":"sec-edgar","filing":"0001439222-26-000101","document":"wk-form4_1782249776.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000101/wk-form4_1782249776.xml","form_type":"4"}},{"id":732520,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:19:18.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 100% of underlying shares on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":766,"derivative":{"exercise_price":499.86,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":766},"source":{"system":"sec-edgar","filing":"0001628280-26-044325","document":"wk-form4_1781813955.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026044325/wk-form4_1781813955.xml","form_type":"4"}},{"id":732519,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:19:18.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units which vest on the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's annual meeting of stockholders to be held in 2027, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":1551,"source":{"system":"sec-edgar","filing":"0001628280-26-044325","document":"wk-form4_1781813955.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026044325/wk-form4_1781813955.xml","form_type":"4"}},{"id":743870,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2026-06-10T20:07:26.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":6111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":6111,"derivative":{"exercise_price":100.64,"expiration_date":"2036-06-07","underlying":"Common Stock","underlying_shares":6111},"source":{"system":"sec-edgar","filing":"0001405288-26-000006","document":"wk-form4_1781122043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140528826000006/wk-form4_1781122043.xml","form_type":"4"}},{"id":743869,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T20:07:26.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":1642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":20968,"source":{"system":"sec-edgar","filing":"0001405288-26-000006","document":"wk-form4_1781122043.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000140528826000006/wk-form4_1781122043.xml","form_type":"4"}},{"id":1102932,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T20:39:48.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 100% of underlying shares on the date of the Issuer's annual meeting of stockholders to be held in 2026, provided that the Reporting Person continues to serve as a director of the Issuer until such date."}],"balance_after":366,"derivative":{"exercise_price":285.73,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":366},"source":{"system":"sec-edgar","filing":"0001628280-25-032855","document":"wk-form4_1750797581.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025032855/wk-form4_1750797581.xml","form_type":"4"}},{"id":1102931,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:39:48.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest on the date of the Issuer's annual meeting of stockholders to be held in 2026, provided the Reporting Person continues in service with the Issuer on such date."}],"balance_after":1097,"source":{"system":"sec-edgar","filing":"0001628280-25-032855","document":"wk-form4_1750797581.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025032855/wk-form4_1750797581.xml","form_type":"4"}},{"id":1103661,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-06-23T20:23:23.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":2120},"source":{"system":"sec-edgar","filing":"0001439222-25-000055","document":"wk-form4_1750710197.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000055/wk-form4_1750710197.xml","form_type":"4"}},{"id":1103660,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-23T20:23:23.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":15768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026."}],"balance_after":15768,"derivative":{"exercise_price":35.5,"expiration_date":"2035-06-18","underlying":"Common stock","underlying_shares":15768},"source":{"system":"sec-edgar","filing":"0001439222-25-000055","document":"wk-form4_1750710197.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000055/wk-form4_1750710197.xml","form_type":"4"}},{"id":1103659,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-06-23T20:23:23.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2816,"derivative":{"underlying":"Common stock","underlying_shares":2816},"source":{"system":"sec-edgar","filing":"0001439222-25-000055","document":"wk-form4_1750710197.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000055/wk-form4_1750710197.xml","form_type":"4"}},{"id":1103658,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-06-23T20:23:23.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":151340,"source":{"system":"sec-edgar","filing":"0001439222-25-000055","document":"wk-form4_1750710197.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000055/wk-form4_1750710197.xml","form_type":"4"}},{"id":1114194,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2025-06-12T20:30:47.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":9216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":9216,"derivative":{"exercise_price":70.07,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":9216},"source":{"system":"sec-edgar","filing":"0001628280-25-031013","document":"wk-form4_1749760237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025031013/wk-form4_1749760237.xml","form_type":"4"}},{"id":1114193,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:30:47.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":2518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":19326,"source":{"system":"sec-edgar","filing":"0001628280-25-031013","document":"wk-form4_1749760237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025031013/wk-form4_1749760237.xml","form_type":"4"}},{"id":1173925,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-04-10T20:02:58.000Z","date":"2025-04-08","kind":"exercise","planned":true,"acquired":false,"shares":15933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on  April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on  April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":15933},"source":{"system":"sec-edgar","filing":"0001439222-25-000029","document":"wk-form4_1744315371.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000029/wk-form4_1744315371.xml","form_type":"4"}},{"id":1173924,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-04-10T20:02:58.000Z","date":"2025-04-10","kind":"sale","planned":true,"acquired":false,"shares":7497,"price":25.9,"value":194172.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated April 8, 2022."}],"balance_after":149220,"source":{"system":"sec-edgar","filing":"0001439222-25-000029","document":"wk-form4_1744315371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000029/wk-form4_1744315371.xml","form_type":"4"}},{"id":1173923,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-04-10T20:02:58.000Z","date":"2025-04-08","kind":"exercise","planned":true,"acquired":true,"shares":15933,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":156717,"source":{"system":"sec-edgar","filing":"0001439222-25-000029","document":"wk-form4_1744315371.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000029/wk-form4_1744315371.xml","form_type":"4"}},{"id":1210315,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-12T20:29:06.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":1579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 50% of the shares on the first anniversary of the date of grant (March 10, 2026) and, thereafter, 12.5% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":1579,"derivative":{"exercise_price":329.16,"expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":1579},"source":{"system":"sec-edgar","filing":"0001628280-25-012364","document":"wk-form4_1741811339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025012364/wk-form4_1741811339.xml","form_type":"4"}},{"id":1210314,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T20:29:06.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 50% of the shares on each of March 10, 2026 and March 10, 2027, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":894,"source":{"system":"sec-edgar","filing":"0001628280-25-012364","document":"wk-form4_1741811339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025012364/wk-form4_1741811339.xml","form_type":"4"}},{"id":1470599,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2024-06-24T20:10:56.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":11774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 20, 2024. The shares underlying this option vest as to 100% of the underlying shares on June 20, 2025."}],"balance_after":11774,"derivative":{"exercise_price":42.45,"expiration_date":"2034-06-20","underlying":"Common stock","underlying_shares":11774},"source":{"system":"sec-edgar","filing":"0001439222-24-000109","document":"wk-form4_1719259849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000109/wk-form4_1719259849.xml","form_type":"4"}},{"id":1470598,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2024-06-24T20:10:56.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units will vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units will vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2120,"derivative":{"underlying":"Common stock","underlying_shares":2120},"source":{"system":"sec-edgar","filing":"0001439222-24-000109","document":"wk-form4_1719259849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000109/wk-form4_1719259849.xml","form_type":"4"}},{"id":1477208,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2024-06-17T21:31:05.000Z","date":"2024-06-13","kind":"exercise","planned":false,"acquired":false,"shares":3388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. The shares underlying the stock units vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. The shares underlying the stock units vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":3388},"source":{"system":"sec-edgar","filing":"0001439222-24-000089","document":"wk-form4_1718659858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000089/wk-form4_1718659858.xml","form_type":"4"}},{"id":1477207,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-06-17T21:31:05.000Z","date":"2024-06-13","kind":"exercise","planned":false,"acquired":true,"shares":3388,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":140784,"source":{"system":"sec-edgar","filing":"0001439222-24-000089","document":"wk-form4_1718659858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000089/wk-form4_1718659858.xml","form_type":"4"}},{"id":1479852,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2024-06-14T16:16:49.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":12517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":12517,"derivative":{"exercise_price":59.94,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":12517},"source":{"system":"sec-edgar","filing":"0000879169-24-000096","document":"wk-form4_1718381801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000096/wk-form4_1718381801.xml","form_type":"4"}},{"id":1479851,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T16:16:49.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":2830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":16808,"source":{"system":"sec-edgar","filing":"0000879169-24-000096","document":"wk-form4_1718381801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000096/wk-form4_1718381801.xml","form_type":"4"}},{"id":1543686,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2024-04-10T20:03:55.000Z","date":"2024-04-08","kind":"exercise","planned":true,"acquired":false,"shares":15934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on  April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on  April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":15933,"derivative":{"underlying":"Common stock","underlying_shares":15934},"source":{"system":"sec-edgar","filing":"0001439222-24-000063","document":"wk-form4_1712779426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000063/wk-form4_1712779426.xml","form_type":"4"}},{"id":1543685,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-04-10T20:03:55.000Z","date":"2024-04-10","kind":"sale","planned":true,"acquired":false,"shares":7791,"price":27.55,"value":214642.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated April 8, 2022."}],"balance_after":137396,"source":{"system":"sec-edgar","filing":"0001439222-24-000063","document":"wk-form4_1712779426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000063/wk-form4_1712779426.xml","form_type":"4"}},{"id":1543684,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-04-10T20:03:55.000Z","date":"2024-04-08","kind":"exercise","planned":true,"acquired":true,"shares":15934,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":145187,"source":{"system":"sec-edgar","filing":"0001439222-24-000063","document":"wk-form4_1712779426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000063/wk-form4_1712779426.xml","form_type":"4"}},{"id":1671970,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance share units","published_at":"2024-01-24T21:22:09.000Z","date":"2024-01-20","kind":"exercise","planned":true,"acquired":false,"shares":23900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The PSUs were granted on April 8, 2022. The PSUs vest upon the achievement of a specified research milestone. The performance criteria for the specified research milestone was determined to have been met on January 20, 2024, resulting in the vesting of the PSUs. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The PSUs were granted on April 8, 2022. The PSUs vest upon the achievement of a specified research milestone. The performance criteria for the specified research milestone was determined to have been met on January 20, 2024, resulting in the vesting of the PSUs. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":23900},"source":{"system":"sec-edgar","filing":"0001439222-24-000016","document":"wk-form4_1706131320.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000016/wk-form4_1706131320.xml","form_type":"4"}},{"id":1671969,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-01-24T21:22:09.000Z","date":"2024-01-24","kind":"sale","planned":true,"acquired":false,"shares":10722,"price":21.64,"value":232024.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated April 8, 2022."}],"balance_after":129253,"source":{"system":"sec-edgar","filing":"0001439222-24-000016","document":"wk-form4_1706131320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000016/wk-form4_1706131320.xml","form_type":"4"}},{"id":1671968,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-01-24T21:22:09.000Z","date":"2024-01-20","kind":"exercise","planned":true,"acquired":true,"shares":23900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":139975,"source":{"system":"sec-edgar","filing":"0001439222-24-000016","document":"wk-form4_1706131320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000016/wk-form4_1706131320.xml","form_type":"4"}},{"id":1682602,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance share units","published_at":"2024-01-09T21:26:55.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The PSUs were granted on February 10, 2021. The PSUs vest upon the achievement of a specified clinical milestone. The performance criteria for the specified clinical milestone was determined to have been met on January 5, 2024, resulting in the vesting of the PSUs. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The PSUs were granted on February 10, 2021. The PSUs vest upon the achievement of a specified clinical milestone. The performance criteria for the specified clinical milestone was determined to have been met on January 5, 2024, resulting in the vesting of the PSUs. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001439222-24-000008","document":"wk-form4_1704835604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000008/wk-form4_1704835604.xml","form_type":"4"}},{"id":1682601,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-01-09T21:26:55.000Z","date":"2024-01-09","kind":"sale","planned":true,"acquired":false,"shares":8391,"price":22.99,"value":192909.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated February 10, 2021."}],"balance_after":116075,"source":{"system":"sec-edgar","filing":"0001439222-24-000008","document":"wk-form4_1704835604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000008/wk-form4_1704835604.xml","form_type":"4"}},{"id":1682600,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-01-09T21:26:55.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":124466,"source":{"system":"sec-edgar","filing":"0001439222-24-000008","document":"wk-form4_1704835604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000008/wk-form4_1704835604.xml","form_type":"4"}},{"id":1841020,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance share units","published_at":"2023-06-30T20:07:56.000Z","date":"2023-06-28","kind":"exercise","planned":true,"acquired":false,"shares":23900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The PSUs vest as to 50% of the underlying shares upon the achievement of a specified clinical milestone and as to 50% of the underlying shares upon the achievement of a specified research milestone. The performance criteria for the specified clinical milestone was determined to have been met on June 28, 2023, resulting in the vesting of the PSUs as to 50% of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The PSUs vest as to 50% of the underlying shares upon the achievement of a specified clinical milestone and as to 50% of the underlying shares upon the achievement of a specified research milestone. The performance criteria for the specified clinical milestone was determined to have been met on June 28, 2023, resulting in the vesting of the PSUs as to 50% of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":23900,"derivative":{"underlying":"Common stock","underlying_shares":23900},"source":{"system":"sec-edgar","filing":"0001439222-23-000107","document":"wk-form4_1688155663.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000107/wk-form4_1688155663.xml","form_type":"4"}},{"id":1841019,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-06-30T20:07:56.000Z","date":"2023-06-30","kind":"sale","planned":true,"acquired":false,"shares":10718,"price":28.36,"value":303962.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units."}],"balance_after":106966,"source":{"system":"sec-edgar","filing":"0001439222-23-000107","document":"wk-form4_1688155663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000107/wk-form4_1688155663.xml","form_type":"4"}},{"id":1841018,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-06-30T20:07:56.000Z","date":"2023-06-28","kind":"exercise","planned":true,"acquired":true,"shares":23900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117684,"source":{"system":"sec-edgar","filing":"0001439222-23-000107","document":"wk-form4_1688155663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000107/wk-form4_1688155663.xml","form_type":"4"}},{"id":1853308,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-16T20:00:29.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":11294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":11294,"derivative":{"exercise_price":61.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":11294},"source":{"system":"sec-edgar","filing":"0001209191-23-037797","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123037797/doc4.xml","form_type":"4"}},{"id":1853307,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:00:29.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":2505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":13978,"source":{"system":"sec-edgar","filing":"0001209191-23-037797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123037797/doc4.xml","form_type":"4"}},{"id":1854217,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2023-06-15T20:29:38.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":18958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 13, 2023. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2024."}],"balance_after":18958,"derivative":{"exercise_price":26.56,"expiration_date":"2033-06-13","underlying":"Common stock","underlying_shares":18958},"source":{"system":"sec-edgar","filing":"0001439222-23-000085","document":"wk-form4_1686860968.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000085/wk-form4_1686860968.xml","form_type":"4"}},{"id":1854216,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2023-06-15T20:29:38.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":3388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":3388,"derivative":{"underlying":"Common stock","underlying_shares":3388},"source":{"system":"sec-edgar","filing":"0001439222-23-000085","document":"wk-form4_1686860968.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000085/wk-form4_1686860968.xml","form_type":"4"}},{"id":1920887,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2023-04-12T20:17:27.000Z","date":"2023-04-08","kind":"exercise","planned":false,"acquired":false,"shares":15933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on  April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on  April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":31867,"derivative":{"underlying":"Common stock","underlying_shares":15933},"source":{"system":"sec-edgar","filing":"0001439222-23-000059","document":"wf-form4_168133063686204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000059/wf-form4_168133063686204.xml","form_type":"4"}},{"id":1920886,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-04-12T20:17:27.000Z","date":"2023-04-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":4731,"price":21.35,"value":101006.85,"ownership":{"direct":true},"balance_after":93784,"source":{"system":"sec-edgar","filing":"0001439222-23-000059","document":"wf-form4_168133063686204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000059/wf-form4_168133063686204.xml","form_type":"4"}},{"id":1920885,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-04-12T20:17:27.000Z","date":"2023-04-08","kind":"exercise","planned":false,"acquired":true,"shares":15933,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":98515,"source":{"system":"sec-edgar","filing":"0001439222-23-000059","document":"wf-form4_168133063686204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000059/wf-form4_168133063686204.xml","form_type":"4"}},{"id":2010881,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2023-02-16T21:03:53.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001439222-23-000024","document":"wf-form4_167658141141317.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000024/wf-form4_167658141141317.xml","form_type":"4"}},{"id":2010880,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-02-16T21:03:53.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":3648,"price":28.91,"value":105463.68,"ownership":{"direct":true},"balance_after":82582,"source":{"system":"sec-edgar","filing":"0001439222-23-000024","document":"wf-form4_167658141141317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000024/wf-form4_167658141141317.xml","form_type":"4"}},{"id":2010879,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-02-16T21:03:53.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":86230,"source":{"system":"sec-edgar","filing":"0001439222-23-000024","document":"wf-form4_167658141141317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000024/wf-form4_167658141141317.xml","form_type":"4"}},{"id":2070430,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:02:11.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":252,"price":80.32,"value":20240.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":11473,"source":{"system":"sec-edgar","filing":"0001209191-23-000801","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123000801/doc4.xml","form_type":"4"}},{"id":2146047,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T20:01:33.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":291,"price":66.64,"value":19392.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":11221,"source":{"system":"sec-edgar","filing":"0001209191-22-052164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122052164/doc4.xml","form_type":"4"}},{"id":2218014,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-01T20:01:22.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":275,"price":75.97,"value":20891.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":10930,"source":{"system":"sec-edgar","filing":"0001209191-22-040182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122040182/doc4.xml","form_type":"4"}},{"id":2228906,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-17T20:01:11.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":9124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":9124,"derivative":{"exercise_price":68.55,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":9124},"source":{"system":"sec-edgar","filing":"0001209191-22-037800","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122037800/doc4.xml","form_type":"4"}},{"id":2228905,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T20:01:11.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":2144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":10655,"source":{"system":"sec-edgar","filing":"0001209191-22-037800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122037800/doc4.xml","form_type":"4"}},{"id":2298384,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted stock units","published_at":"2022-04-12T20:01:36.000Z","date":"2022-04-08","kind":"grant","acquired":true,"shares":47800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on  April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on  April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":47800,"derivative":{"underlying":"Common stock","underlying_shares":47800},"source":{"system":"sec-edgar","filing":"0001439222-22-000032","document":"wf-form4_164979367185851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000032/wf-form4_164979367185851.xml","form_type":"4"}},{"id":2298383,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options (right to buy)","published_at":"2022-04-12T20:01:36.000Z","date":"2022-04-08","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 8, 2022. The shares underlying this option vest as to 25% of the underlying shares on April 8, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":170000,"derivative":{"exercise_price":29.46,"expiration_date":"2032-04-08","underlying":"Common stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001439222-22-000032","document":"wf-form4_164979367185851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000032/wf-form4_164979367185851.xml","form_type":"4"}},{"id":2309731,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:00:51.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":280,"price":79.42,"value":22237.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":8511,"source":{"system":"sec-edgar","filing":"0001209191-22-022293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122022293/doc4.xml","form_type":"4"}},{"id":2378318,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance share units","published_at":"2022-02-23T21:10:29.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":12379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified regulatory milestone was determined to have been met on February 18, 2022, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified regulatory milestone was determined to have been met on February 18, 2022, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":12380,"derivative":{"underlying":"Common stock","underlying_shares":12379},"source":{"system":"sec-edgar","filing":"0001439222-22-000017","document":"wf-form4_164565061538990.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000017/wf-form4_164565061538990.xml","form_type":"4"}},{"id":2378317,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2022-02-23T21:10:29.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":3674,"price":29.08,"value":106839.92,"ownership":{"direct":true},"balance_after":74897,"source":{"system":"sec-edgar","filing":"0001439222-22-000017","document":"wf-form4_164565061538990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000017/wf-form4_164565061538990.xml","form_type":"4"}},{"id":2378316,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2022-02-23T21:10:29.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":12379,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":78571,"source":{"system":"sec-edgar","filing":"0001439222-22-000017","document":"wf-form4_164565061538990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000017/wf-form4_164565061538990.xml","form_type":"4"}},{"id":2391726,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted stock units","published_at":"2022-02-16T22:01:39.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":11334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":11333,"derivative":{"underlying":"Common stock","underlying_shares":11334},"source":{"system":"sec-edgar","filing":"0001439222-22-000012","document":"wf-form4_164504888183057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000012/wf-form4_164504888183057.xml","form_type":"4"}},{"id":2391725,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2022-02-16T22:01:39.000Z","date":"2022-02-14","kind":"tax_withholding","acquired":false,"shares":3505,"price":30.5,"value":106902.5,"ownership":{"direct":true},"balance_after":66192,"source":{"system":"sec-edgar","filing":"0001439222-22-000012","document":"wf-form4_164504888183057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000012/wf-form4_164504888183057.xml","form_type":"4"}},{"id":2391724,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2022-02-16T22:01:39.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":11334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":69697,"source":{"system":"sec-edgar","filing":"0001439222-22-000012","document":"wf-form4_164504888183057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000012/wf-form4_164504888183057.xml","form_type":"4"}},{"id":2451964,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T21:16:24.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":289,"price":73.4,"value":21212.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":8231,"source":{"system":"sec-edgar","filing":"0001209191-22-000702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122000702/doc4.xml","form_type":"4"}},{"id":2553177,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T20:32:44.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":271,"price":68.78,"value":18639.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":7942,"source":{"system":"sec-edgar","filing":"0001209191-21-058982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121058982/doc4.xml","form_type":"4"}},{"id":2646194,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T11:19:46.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":238,"price":84.13,"value":20022.94,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":7671,"source":{"system":"sec-edgar","filing":"0001209191-21-044644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121044644/doc4.xml","form_type":"4"}},{"id":2692172,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-28T11:10:36.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":8010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":8010,"derivative":{"exercise_price":83.16,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":8010},"source":{"system":"sec-edgar","filing":"0001209191-21-036405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121036405/doc4.xml","form_type":"4"}},{"id":2692171,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T11:10:36.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":1923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":7433,"source":{"system":"sec-edgar","filing":"0001209191-21-036405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121036405/doc4.xml","form_type":"4"}},{"id":2765264,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-01T21:53:43.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":251,"price":81.27,"value":20398.77,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":5510,"source":{"system":"sec-edgar","filing":"0001209191-21-024210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121024210/doc4.xml","form_type":"4"}},{"id":2854263,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted stock units","published_at":"2021-02-17T21:13:48.000Z","date":"2021-02-14","kind":"exercise","acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":22667,"derivative":{"underlying":"Common stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001439222-21-000011","document":"wf-form4_161359639686404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000011/wf-form4_161359639686404.xml","form_type":"4"}},{"id":2854262,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2021-02-17T21:13:48.000Z","date":"2021-02-14","kind":"tax_withholding","acquired":false,"shares":3398,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":58363,"source":{"system":"sec-edgar","filing":"0001439222-21-000011","document":"wf-form4_161359639686404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000011/wf-form4_161359639686404.xml","form_type":"4"}},{"id":2854261,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2021-02-17T21:13:48.000Z","date":"2021-02-14","kind":"exercise","acquired":true,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61761,"source":{"system":"sec-edgar","filing":"0001439222-21-000011","document":"wf-form4_161359639686404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000011/wf-form4_161359639686404.xml","form_type":"4"}},{"id":2863117,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-02-12T21:24:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":163000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":163000,"derivative":{"exercise_price":56.68,"expiration_date":"2031-02-10","underlying":"Common stock","underlying_shares":163000},"source":{"system":"sec-edgar","filing":"0001439222-21-000007","document":"wf-form4_161316500956020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000007/wf-form4_161316500956020.xml","form_type":"4"}},{"id":2923332,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:51:51.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":237,"price":86.98,"value":20614.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":5259,"source":{"system":"sec-edgar","filing":"0001209191-21-001217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121001217/doc4.xml","form_type":"4"}},{"id":3019187,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T20:48:44.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":219,"price":89.74,"value":19653.06,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":5022,"source":{"system":"sec-edgar","filing":"0001209191-20-052637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120052637/doc4.xml","form_type":"4"}},{"id":3095796,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-01T22:02:05.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":202,"price":103.97,"value":21001.94,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":4803,"source":{"system":"sec-edgar","filing":"0001209191-20-039885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120039885/doc4.xml","form_type":"4"}},{"id":3132800,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-28T20:18:29.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":10514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":10514,"derivative":{"exercise_price":98.68,"expiration_date":"2030-05-25","underlying":"Common Stock","underlying_shares":10514},"source":{"system":"sec-edgar","filing":"0001209191-20-032592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120032592/doc4.xml","form_type":"4"}},{"id":3132799,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-28T20:18:29.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":1282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":4601,"source":{"system":"sec-edgar","filing":"0001209191-20-032592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120032592/doc4.xml","form_type":"4"}},{"id":3176460,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance share units","published_at":"2020-04-15T20:26:20.000Z","date":"2020-04-13","kind":"exercise","acquired":false,"shares":12379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service.  The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date.  Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service.  The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date.  Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":24759,"derivative":{"underlying":"Common stock","underlying_shares":12379},"source":{"system":"sec-edgar","filing":"0001439222-20-000030","document":"wf-form4_158698236240236.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/wf-form4_158698236240236.xml","form_type":"4"}},{"id":3176459,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2020-04-15T20:26:20.000Z","date":"2020-04-14","kind":"tax_withholding","acquired":false,"shares":3673,"price":40.64,"value":149270.72,"ownership":{"direct":true},"balance_after":50428,"source":{"system":"sec-edgar","filing":"0001439222-20-000030","document":"wf-form4_158698236240236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/wf-form4_158698236240236.xml","form_type":"4"}},{"id":3176458,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2020-04-15T20:26:20.000Z","date":"2020-04-13","kind":"exercise","acquired":true,"shares":12379,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":54101,"source":{"system":"sec-edgar","filing":"0001439222-20-000030","document":"wf-form4_158698236240236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/wf-form4_158698236240236.xml","form_type":"4"}},{"id":3187731,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T21:18:10.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":270,"price":73.23,"value":19772.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":3319,"source":{"system":"sec-edgar","filing":"0001209191-20-022695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120022695/doc4.xml","form_type":"4"}},{"id":3196916,"issuer":{"id":556,"kind":"organization","name":"DICK'S SPORTING GOODS, INC.","symbol":"DKS"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2020-03-24T20:32:59.000Z","date":"2020-03-22","kind":"grant","acquired":true,"shares":9518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of time-based restricted stock, subject to vesting."}],"balance_after":55288,"source":{"system":"sec-edgar","filing":"0001089063-20-000035","document":"wf-form4_158508196150334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089063/000108906320000035/wf-form4_158508196150334.xml","form_type":"4"}},{"id":3262921,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted stock units","published_at":"2020-02-19T21:52:48.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on February 14, 2020. Beginning on February, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on February 14, 2020. Beginning on February, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":34000,"derivative":{"underlying":"Common stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001439222-20-000017","document":"wf-form4_158214915116382.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000017/wf-form4_158214915116382.xml","form_type":"4"}},{"id":3262920,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-02-19T21:52:48.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":137000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":137000,"derivative":{"exercise_price":51.51,"expiration_date":"2030-02-14","underlying":"Common stock","underlying_shares":137000},"source":{"system":"sec-edgar","filing":"0001439222-20-000017","document":"wf-form4_158214915116382.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000017/wf-form4_158214915116382.xml","form_type":"4"}},{"id":3324924,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T21:15:22.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":218,"price":87.32,"value":19035.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":3049,"source":{"system":"sec-edgar","filing":"0001209191-20-000886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120000886/doc4.xml","form_type":"4"}},{"id":3369822,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2019-11-15T21:05:09.000Z","date":"2019-11-13","kind":"purchase","acquired":true,"shares":40322,"price":31,"value":1249982.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All shares were purchased at $31.00 per share in an underwritten public offering that closed on November 13, 2019."}],"balance_after":41722,"source":{"system":"sec-edgar","filing":"0001439222-19-000025","document":"wf-form4_157385189418467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/wf-form4_157385189418467.xml","form_type":"4"}},{"id":3401875,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T20:14:53.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":251,"price":74.23,"value":18631.73,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":2831,"source":{"system":"sec-edgar","filing":"0001209191-19-051647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119051647/doc4.xml","form_type":"4"}},{"id":3472910,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T20:39:36.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":203,"price":84.96,"value":17246.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":2580,"source":{"system":"sec-edgar","filing":"0001209191-19-040335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119040335/doc4.xml","form_type":"4"}},{"id":3506278,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted stock units","published_at":"2019-05-31T20:05:43.000Z","date":"2019-05-31","kind":"exercise","acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on May 31, 2018. The shares underlying the stock units vested in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on May 31, 2018. The shares underlying the stock units vested in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-19-033620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/doc4.xml","form_type":"4"}},{"id":3506277,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2019-05-31T20:05:43.000Z","date":"2019-05-31","kind":"exercise","acquired":true,"shares":1400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":1400,"source":{"system":"sec-edgar","filing":"0001209191-19-033620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/doc4.xml","form_type":"4"}},{"id":3546953,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-29T21:11:47.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":12472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":12472,"derivative":{"exercise_price":75.03,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":12472},"source":{"system":"sec-edgar","filing":"0001209191-19-026439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119026439/doc4.xml","form_type":"4"}},{"id":3546952,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-29T21:11:47.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":1520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":2377,"source":{"system":"sec-edgar","filing":"0001209191-19-026439","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119026439/doc4.xml","form_type":"4"}},{"id":3561898,"issuer":{"id":556,"kind":"organization","name":"DICK'S SPORTING GOODS, INC.","symbol":"DKS"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2019-04-05T18:56:00.000Z","date":"2019-04-03","kind":"grant","acquired":true,"shares":4181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of time-based restricted stock, subject to vesting."}],"balance_after":45770,"source":{"system":"sec-edgar","filing":"0001089063-19-000020","document":"wf-form4_155449054641329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089063/000108906319000020/wf-form4_155449054641329.xml","form_type":"4"}},{"id":3570319,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T20:47:55.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":145,"price":86.01,"value":12471.45,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."}],"balance_after":857,"source":{"system":"sec-edgar","filing":"0001209191-19-022599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119022599/doc4.xml","form_type":"4"}},{"id":3674104,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance share units","published_at":"2019-02-05T21:28:21.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":42695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The performance share units vest if, during the five-year period beginning on February 1, 2019 and ending on February 1, 2024, the closing price of the issuer's common stock equals or exceeds $120 per share for at least 20 consecutive trading days at any time during such five-year period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The performance share units vest if, during the five-year period beginning on February 1, 2019 and ending on February 1, 2024, the closing price of the issuer's common stock equals or exceeds $120 per share for at least 20 consecutive trading days at any time during such five-year period."}],"balance_after":42695,"derivative":{"expiration_date":"2024-02-01","underlying":"Common stock","underlying_shares":42695},"source":{"system":"sec-edgar","filing":"0001209191-19-007343","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119007343/doc4.xml","form_type":"4"}},{"id":3674103,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-02-05T21:28:21.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":350346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 1, 2019. The shares underlying this option vest as to 25% of the shares on February 1, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":350346,"derivative":{"exercise_price":53.87,"expiration_date":"2029-01-31","underlying":"Common stock","underlying_shares":350346},"source":{"system":"sec-edgar","filing":"0001209191-19-007343","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119007343/doc4.xml","form_type":"4"}},{"id":3710970,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-03T21:12:32.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":196,"price":63.59,"value":12463.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."}],"balance_after":712,"source":{"system":"sec-edgar","filing":"0001209191-19-000904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119000904/doc4.xml","form_type":"4"}},{"id":3803148,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-02T20:19:03.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":180,"price":69.08,"value":12434.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."}],"balance_after":516,"source":{"system":"sec-edgar","filing":"0001209191-18-053114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118053114/doc4.xml","form_type":"4"}},{"id":3877018,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":35960,"kind":"person","name":"FOUSE JACQUALYN A","position":1,"cik":"0001405288","reported_name":"FOUSE JACQUALYN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T20:02:39.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":186,"price":67,"value":12462.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."}],"balance_after":336,"source":{"system":"sec-edgar","filing":"0001209191-18-040920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919118040920/doc4.xml","form_type":"4"}}],"next_cursor":"2018-07-03T20:02:39.000000Z,3877018"}